DNA ploidy in nonmelanoma skin cancer

Cancer

Volumn 77, Issue 2, 1996, Pages 284-291

  Robinson, June K ^a   Rademaker, Alfred W ^a   Goolsby, Charles ^a   Traczyk, Thomas N ^a   Zoladz, Carol ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

DNA ploidy; metastasis; nonmelanoma skin cancer; prognosis

Indexed keywords

ANEUPLOIDY; ARTICLE; CELL CYCLE S PHASE; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; DNA DETERMINATION; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; SKIN CANCER; TETRAPLOIDY;

ADULT; AGED; ANEUPLOIDY; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; PLOIDIES; S PHASE; SKIN NEOPLASMS;

EID: 0030040635     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960115)77:2<284::AID-CNCR10>3.0.CO;2-Y     Document Type: Article

References (56)

1. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994;30:774-8.
2. Weinstock MA. Nonmelanoma skin cancer mortality in the United States, 1969 through 1988. Arch Dermatol 1993;129:1286-90.
3. Sidransky D, Boyle J, Koch W. Molecular screening. Arch Otolaryngol Head Neck Surg 1993;119:1187-90.
4. Johansen LV, Mestre M, Overgaard J. Carcinoma of the nasopharynx: analysis of treatment results in 167 consecutively admitted patients. Head Neck 1992;14:200-7.
5. Platz H, Fries R, Hudec M, Tjoa AM, Wagner RR. The prognostic relevance of various factors at the time of the first admission of the patient. J Oral Maxillofac Surg 1983;11:3-12.
6. Sexton M, Jones DB, Maloney ME. Histologic pattern analysis of basal cell carcinoma. J Am Acad Dermatol 1990;23:1118-26.
7. Rowe DE, Carroll RJ, Day CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. J Am Acad Dermatol 1992;26:976-90.
8. Stein AL, Tahan SR. Histologic correlates of metastasis in primary invasive squamous cell carcinoma of the lip. J Cutan Pathol 1994;21:16-21.
9. Fee WE, Shoeppel SL, Rubenstein R, Goffinet DR, Goode RL, Boles R, et al. Squamous cell carcinoma of the soft palate. Arch Otolaryngol Head Neck Surg 1979;105:710-8.
10. Tong D, Laramore GE, Griffin TW, Russell AH, Tesh DW, Taylor WJ, et al. Carcinoma of the tonsillar region. Cancer 1982;49:2009-14.
11. Roland NJ, Caslin AW, Nash J, Stell PM. Value of grading squamous cell carcinoma of the head and neck. Head Neck 1992;14:224-9.
12. Crissman JD, Liu WY, Gluckman JL, Cummings G. Prognostic value of histopathologic parameters in squamous cell carcinoma of the oropharynx. Cancer 1984;54:2995-3001.
13. Close LG, Burns DK, Reisch J, Schaefer SD. Microvascular invasion in cancer of the oral cavity and oropharynx. Otolaryngol Head Neck Surg 1987;113:1191-5.
14. Polesksic S, Kalwoic HJ. Prognostic value of vascular invasion in squamous cell carcinoma of the head and neck. Plast Reconstr Surg 1978;61:234-40.
15. Goldsmith MM, Cresson DH, Askin FB II: The prognostic significance of stromal eosinophilia in head and neck cancer. Otolaryngol Head Neck Surg 1987;96:319-24.
16. Jakobsson PA. Histologic grading of malignancy and prognosis in glottic carcinoma of the larynx. Workshop No 14. In: Alberti PW, Bryce DP, editors. Centennial conference on laryngeal cancer. New York, NY: Appleton-Century-Crofts, 1976:847-52.
17. Viehl P, Magdelénat H, Remvikos Y, Dutrillaux B. Analysis of DNA content. In: Viehl P, editor. Guides to clinical aspiration biopsy flow cytometry. New York, NY: Igaku-Shoin, 1992:21-32.
18. Dressier LG, Bartow SA: DNA flow cytometry in solid tumors: practical aspects and clinical applications. Semin Diagn Pathol 1989;6:55-82.
19. Kearsley JH, Bryson G, Battistutta D, Collins RJ. Prognostic importance of cellular DNA content in head-and-neck squamous cell cancers: a comparison of retrospective and prospective series, Int J Cancer 1991;47:31-7.
20. Rua S, Comino A, Fruttero A, Cera G, Semeria C, Lanzillotta L, et al. Relationship between histologic features, DNA flow cytometry and clinical behavior of squamous cell carcinomas of the larynx. Cancer 1991;67:141-9.
21. Hemmer J, Kreidler J. Flow cytometric DNA ploidy analysis of squamous cell carcinoma of the oral cavity: comparison with clinical staging and histological grading. Cancer 1990;66:317-20.
22. Moran R, Black M, Alpert L. Correlation of cell-cycle kinetics, hormone receptors, histopathology and nodal status in human breast cancer. Cancer 1984;54:1586-90.
23. Gustafson H, Tribukait B, Esposti PL. DNA profile and tumor progression in patients with superficial bladder tumors. Urol Res 1982;10:13-8.
24. van Roenn JH, Kheir SM, Walter JM, Coon JS. Significance of DNA abnormalities in primary malignant melanoma and nevi: a retrospective flow cytometric study. Cancer Res 1986;46:3192-5.
25. Wiggers T, Arends JW, Schutte B, Volovics L, Bosman FT. A multivariate analysis of pathologic prognostic indicators of large bowl cancer. Cancer 1988;61:386-95.
26. Tirindelli-Danesi D, Tedori L, Mauro F, Modini C, Botti C, Cicconetti F, et al. Prognostic significance of flow cytometry in lung cancer. A 5-year study. Cancer 1987;60:844-51.
27. Schuman J: Ploidy and proliferation characteristics of human solid tumors. Fourth International Symposium Flow Cytometry. Voss, Norway, June XX-XX, 1979.
28. Tubiana M. Repopulation in human tumors: a biological background for fractionation in radiotherapy. Acta Oncol 1988;27:83-8.
29. Breur K. Growth rate and radiosensitivity of human tumors. Eur J Cancer 1966;2:173-88.
30. Morton DL, Davtyon DG, Wanek LA, Foshag LJ, Cochran AJ. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness. Cancer 1993;71:3737-43.
31. Park KGM, Blessing K, Mcharen KM, Watson ACH. A study of thin (< 1.5 mm) malignant melanomas with poor prognosis. Br J Plast Surg 1993;46:607-10.
32. Tromovitch TA, Stegman SJ. Microscopically-controlled excision of cutaneous tumors. Cancer 1978;41:653-8.
33. Vindelov LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983;3:323-7.
34. Rabinovitch PS. Practical considerations for DNA content and cell cycle analysis. In: Bauer KD, Duque RE, Shankey TV, editors. Clinical flow cytometry principles and applications. Philadelphia: William and Wilkins, 1993:117-42.
35. Hiddemann W, Schumann J, Andreeff M, Barlogie B, Herman CJ, Leif RC, et al. Convention on nomenclature for DNA cytometry. Cytometry 1984;5:445-6.
36. Shankey TV, Rabinovitch PS, Bagwell B, Bauer KD, Duque RE, Hedley DW, et al. Guidelines for implementation of clinical DNA cytometry. Cytometry 1993;14:472-7.
37. Frentz G, Moller U: Clonal heterogeneity in curetted human epidermal cancers and precancers analyzed by flow cytometry and compared with histology. Br J Dermatol 1983;109:173-81.
38. Randall MB, Geisinger KR, Kute TE, Buss DH, Prichard RW. DNA content and proliferative index in cutaneous squamous cell carcxinoma and keratoacanthoma. Am J Clin Pathol 1990;93:259-62.
39. Frentz G, Moller U, Larsen JK: DNA flow cytometry of human epidermal tumors. Virchows Archiv (B) Cell Pathol Incl Mol Pathol 1985;48:175-83.
40. Zemtsov A, Koss W, Dixon L, Tyring S, Rady P. Anal verrucous carcinoma associated with human papillomavirus type II: magnetic resonance imaging and flow cytometry evaluation. Arch Dermatol 1992;128:564-5.
41. Pappas A, Maners AW, Owens RB, Thompson JR. King JC, Dinehart SM. Deoxyribonucleic acid (DNA) ploidy and proliferation characteristics of metastatic squamous cell carcinoma determined by flow cytometric analysis. J Dermatol Surg Oncol 1992;18:957-60.
42. Herzberg AJ, Kerns BJ, Pollack SV, Kinney RB. DNA image cytometry of keratoacanthoma and squamous cell carcinoma. J Invest Dermatol 1991;97:495-500.
43. Tuthill RJ, McGillis ST, Guitart J. DNA flow cytometry of basal cell carcinoma [Abstract]. J Cutan Pathol 1990;17:322.
44. Garcia JA, Cohen PR, Herzberg AJ, Wallis ME, Rapini RP. Pleomorphic basal cell carcinoma. J Am Acad Dermatol 1995;32:740-6.
45. Johnson TS, Williamson KD, Cramer MM, Peters LJ. Flow cytometric analysis of head and neck carcinoma DNA index and S-fraction from paraffin-embedded sections: comparison with malignancy grading. Cytometry 1985;6:461-70.
46. Holm LE. Cellular DNA amounts of squamous cell carcinomas of the head and neck region in relation to prognosis. Laryngoscope 1982;92:1064-9.
47. Ensley JF, Maciorowski Z, Hassan M, Pietraszkiewicz H, Sakr W, Heilbrun LK. Variations in DNA aneuploid cell content during tumor dissociation in human colon and head and neck cancers analyzed by flow cytometry. Cytometry 1993;14:550-8.
48. Bijman JT, Wagener H, van Rennes H, Wessels JMC, van den Brock P. Flow cytometric evaluation of cell dispersion from human head and neck tumors. Cytometry 1985;6:334-41.
49. Visscher DW, Zarbo RJ, Jacobsen G, Kambourd A, Talpos G, Sakr W, et al. Multiparametric deoxyribonucleic acid and cell cycle analysis of breast carcinomas by flow cytometry. Lab Invest 1990;62:370-8.
50. Bauer KD, Lincoln ST, Vera-Roman JM, Wallemark CB, Chmiel JS, Madurski ML, et al. Prognostic implications of proliferative activity and DMA aneuploidy in colonic adenocarcinomas. Lab Invest 1987;57:329-35.
51. Mittal KR, Schwartz, PE, Barwick KW: Architectural (FIGO) grading, nuclear grading, and other prognostic indicators in Stage I endometrial adenocarcinoma with identification of high-risk and low-risk groups. Cancer 1988;61:538-45.
52. Ho JHC. An epidemiologic and clinical study of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1978;4:183-98.
53. Banner BF, De La Vega T, Roseman DL, Coon JS. Should flow cytometric DNA analysis precede definitive surgery for colon carcinoma? Ann Surg 1985;202:740-4.
54. Harari PM, Contreras L, Pickart MA, Ritter MA, Kinsella TJ. Modulation of proliferation kinetics in human squamous cell carcinomas of the head and neck. Arch Otolaryngol Head Neck Surg 1993;119:738-42.
55. Tennvall J, Wennerberg J, Anderson H, Baldetorp B, Ferno M, Willen R. DNA analysis as a predictor of the outcome of induction chemotherapy in advanced head and neck carcinomas. Arch Otolaryngol Head Neck Surg 1993;119:867-70.
56. Geohas J, Roholt NS, Robinson JK. Adjuvant radiotherapy after excision of cutaneous squamous cell carcinoma. J Am Acad Dermatol 1994;30:633-6.